Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Holy Stone Healthcare Co FCF Yield % Related Terms
Holy Stone Healthcare Co FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4194 vs VRTX, REGN, ALNY: FCF Yield % Comparison
For the Biotechnology subindustry, Holy Stone Healthcare Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Holy Stone Healthcare Co FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Holy Stone Healthcare Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Holy Stone Healthcare Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Holy Stone Healthcare Co (ROCO:4194) has a FCF Yield % of -11.41 as of Jul. 21, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Holy Stone Healthcare Co and its competitors. According to the industry distribution chart, Holy Stone Healthcare Co ranks #772 out of 1409 companies in the Biotechnology industry, placing it in the top 54.8%.
Is Holy Stone Healthcare Co's FCF Yield % too high?
Holy Stone Healthcare Co's current FCF Yield % is -11.41. Based on the distribution chart, Holy Stone Healthcare Co ranks #772 out of 1409 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Holy Stone Healthcare Co has a GF Score™ of 41/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Holy Stone Healthcare Co's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Holy Stone Healthcare Co ranks #772 out of 1409 companies for FCF Yield %. This places Holy Stone Healthcare Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Holy Stone Healthcare Co and its competitors. Holy Stone Healthcare Co's current FCF Yield % is -11.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Holy Stone Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Holy Stone Healthcare Co (ROCO:4194) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$3.93, compared to a current price of NT$6.99 — trading 77.9% above its estimated fair value. The current FCF Yield % is -11.41. Holy Stone Healthcare Co's overall GF Score™ is 41/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Holy Stone Healthcare Co (ROCO:4194), the current FCF Yield % is -11.41 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Holy Stone Healthcare Co (ROCO:4194) Overvalued in 2026?
Based on GuruFocus' analysis, Holy Stone Healthcare Co stock appears to be overvalued.
The current stock price of NT$6.99 is trading 77.9% above its estimated GF Value™ of NT$3.93.
GuruFocus considers Holy Stone Healthcare Co to be Significantly Overvalued.
Key valuation signals for ROCO:4194:
FCF Yield %: -11.41
GF Value™: NT$3.93 vs. price of NT$6.99 (77.9% above fair value)
No single metric tells the full story. See the ROCO:4194 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Holy Stone Healthcare Co Ltd is a Taiwan based company focused on a biopolymer drug delivery platform. It is involved in the development of new drugs and medical devices, especially hyaluronic acid related therapeutic products. The products of the company include RenehaVis, SportVis, TRUD, and GAF.
41GF Score
Get the complete analysis for ROCO:4194
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4194 has been successfully added to your 
